Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Withdrawn 1Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1Genitourinary 1

Conditions

Uterine Cervical Neoplasms 69Prostatic Neoplasms 47Breast Neoplasms 14Sarcoma 10Neoplasms 10Endometrial Neoplasms 9Vaginal Neoplasms 7Esophageal Neoplasms 6Uterine Neoplasms 4Radiation Injuries 4Lung Neoplasms 4Liver Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Adenocarcinoma 4Vulvar Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 3Hyperthermia 3Gliosarcoma 3Desmoplastic Small Round Cell Tumor 3Central Nervous System Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Breast Carcinoma In Situ 3Brain Neoplasms 3Uveal Melanoma 2Rhabdomyosarcoma 2Retinoblastoma 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2

Interventions

Oxaliplatin 46Gemcitabine 45Fluorouracil 40Capecitabine 31pembrolizumab 29Leucovorin 29Docetaxel 27Cisplatin 25Paclitaxel 23Irinotecan 18Carboplatin 18Bevacizumab 18130-nm albumin-bound paclitaxel 17Pemetrexed 15Albumin-Bound Paclitaxel 15Radiotherapy 14Nivolumab 12Ramucirumab 11Cyclophosphamide 11Trastuzumab 8Erlotinib Hydrochloride 8Taxes 7Radiosurgery 7Drug Therapy 7cemiplimab 6zolbetuximab 5trastuzumab deruxtecan 5regorafenib 5durvalumab 5Sorafenib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Adenocarcinoma × Brachytherapy × Clear all
NCT07182279 2026-03-09

Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

The Methodist Hospital Research Institute

Phase 1/2 Recruiting
29 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT01485731 2015-06-03

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

University of Miami

Phase 1 Completed
8 enrolled
Gynecologic

Adenocarcinoma, Uterine Cervical Neoplasms, Neoplasms

NCT01301612 2014-07-14

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Eurofarma Laboratorios S.A.

Phase 2 Withdrawn
Tumor-Agnostic

Adenocarcinoma, Carcinoma

NCT01786278 2013-02-07

BRASTEGAC

Medical University of Lublin

Phase 2/3 Unknown
80 enrolled

Adenocarcinoma, Deglutition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡